300357 我武生物
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)4.45115.32014.00514.89618.773
总资产报酬率 ROA (%)4.08813.58912.05913.03316.890
投入资产回报率 ROIC (%)4.41815.10313.57314.42118.506

边际利润分析
销售毛利率 (%)95.24595.23995.15895.26295.393
营业利润率 (%)52.63941.26739.88740.67244.219
息税前利润/营业总收入 (%)50.36038.57936.15737.31241.799
净利润/营业总收入 (%)46.08134.64732.88734.84137.469

收益指标分析
经营活动净收益/利润总额(%)78.09298.65794.99496.618102.515
价值变动净收益/利润总额(%)23.8491.4211.7720.3600.676
营业外收支净额/利润总额(%)-0.994-1.320-1.1090.2840.637

偿债能力分析
流动比率 (X)26.13712.1829.0458.86714.376
速动比率 (X)25.34211.8048.7298.53413.905
资产负债率 (%)3.7136.4089.23910.0887.769
带息债务/全部投入资本 (%)-0.777-0.839-0.6390.467-1.137
股东权益/带息债务 (%)-12,771.176-11,836.684-15,316.14920,537.318-8,595.943
股东权益/负债合计 (%)2,511.7031,410.804940.372845.4291,159.304
利息保障倍数 (X)-28.593-17.945-10.984-10.734-15.460

营运能力分析
应收账款周转天数 (天)72.01953.57957.57166.65065.734
存货周转天数 (天)405.904400.307469.069481.237445.498